RenovoRx, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by RenovoRx, Inc. (RNXT) on July 13, 2022, with the earliest event reported on that date. The filing addresses significant changes in executive leadership, specifically the departure of the Chief Financial Officer and the appointment of a successor.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and personnel changes. The only financial detail disclosed relates to the compensation arrangement for the new CFO, who is engaged through a consulting firm at an hourly rate of $450.
Material Changes
- Departure of CFO: Christopher J. Lehman resigned as Chief Financial Officer, effective July 15, 2022.
- Appointment of New CFO: James Ahlers was appointed as Chief Financial Officer, Secretary, and Treasurer, effective July 15, 2022. He will serve as the principal financial and accounting officer.
- Employment Structure: Mr. Ahlers is an employee of Danforth Advisors, LLC, which provides CFO advisory services. The Company entered into a consulting agreement with Danforth on April 25, 2022.
Outlook, Risks, and Management Commentary
Management confirmed that the selection of Mr. Ahlers was not part of any arrangement with other persons and that there are no family relationships between Mr. Ahlers and existing directors or officers. The consulting agreement allows for termination with cause upon 30 days' notice or without cause upon 60 days' notice. A press release detailing these changes was issued on July 19, 2022.
Key Facts for Investor Verification
- Verify the transition timeline for the CFO role, noting the effective date of July 15, 2022.
- Review the Consulting Agreement (Exhibit 10.1) for specific terms regarding the $450 hourly rate and expense reimbursements.
- Confirm Mr. Ahlers' background, including his prior role as CFO of Intarcia Therapeutics, Inc. (2002-2019).
- Note that the filing does not contain updated financial statements or guidance.